-
81
Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes
Published 2017-01-01“…To evaluate the predictive factors of long-term visual outcomes in neovascular age-related macular degeneration (nAMD) treated with antivascular endothelial growth factor (anti-VEGF) agents. …”
Get full text
Article -
82
Comparison of OCT Angiography Parameters after Administration of Intravitreal Brolucizumab versus Ranibizumab in Exudative Age-related Macular Degeneration
Published 2024-12-01“…Purpose: To compare the OCT angiography (OCTA)–derived parametric changes before and after intravitreal administration of ranibizumab and brolucizumab in patients with neovascular age-related macular degeneration (ARMD) and to compare the changes between the two groups. …”
Get full text
Article -
83
Charles Bonnet syndrome in patients with geographic atrophy secondary to age-related macular degeneration: a cross-sectional study
Published 2025-01-01“…Background: Age-related macular degeneration (AMD) is a prevalent cause of irreversible vision loss among the elderly. …”
Get full text
Article -
84
Association between relative telomere length and a genetic variant of SIRT1 gene and age-related macular degeneration
Published 2021-09-01“…</i> </p> <p> <i><b>Keywords</b>: age-related macular degeneration, relative telomere length, rs12778366, SIRT1 gene, age-related diseases, buccal epithelium, genetic testing.…”
Get full text
Article -
85
-
86
Predictive value of different baseline optical coherence tomography biomarkers for visual acuity changes in neovascular age-related macular degeneration
Published 2025-02-01Subjects: “…Age-related macular degeneration…”
Get full text
Article -
87
Smaller-incision new-generation implantable miniature telescope in late-stage age-related macular degeneration: 6 month outcomes
Published 2025-01-01Subjects: “…Age-related macular degeneration…”
Get full text
Article -
88
Comparison of Progression Rate of Retinal Pigment Epithelium Loss in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Aflibercept
Published 2017-01-01“…Retinal pigment epithelium (RPE) loss in neovascular age-related macular degeneration (nAMD) seem to have a linear progression but might be influenced by the treatment. …”
Get full text
Article -
89
Association of age-related macular degeneration on fracture risks among osteoporosis population: a nationwide population-based cohort study
Published 2020-09-01“…Objectives Visual impairment is an important risk factor for fracture in the elderly population. Age-related macular degeneration (AMD) is the leading cause of irreversible visual impairment in elderly people. …”
Get full text
Article -
90
Emotional and physical experiences of people with neovascular age-related macular degeneration during the injection process in Germany: a qualitative study
Published 2022-06-01“…Experiencing neovascular macular degeneration was dominated by the injection experience. …”
Get full text
Article -
91
Neovascular age-related macular degeneration: disease pathogenesis and current state of molecular biomarkers predicting treatment response—a scoping review
Published 2024-05-01“…Age-related macular degeneration is a major cause of blindness, and the development of anti-vascular endothelial growth factor (VEGF) intravitreal treatments has revolutionised the management of the disease. …”
Get full text
Article -
92
-
93
Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany
Published 2020-01-01“…To date, there are limited prospective real-world data on the impact of optical coherence tomography (OCT) diagnostics on treatment outcomes in neovascular age-related macular degeneration (nAMD). Therefore, the prospective, noninterventional OCEAN study (NCT02194803) evaluated the use of OCT imaging and its impact on functional outcomes in Germany. …”
Get full text
Article -
94
Three-Year Outcomes of Patients with Neovascular Age-Related Macular Degeneration Treated with Aflibercept under the National Health Insurance Program in Taiwan
Published 2020-01-01“…To observe and analyze the long-term outcomes of patients with neovascular age-related macular degeneration (nAMD) treated with aflibercept monotherapy under the National Health Insurance (NHI) program in Taiwan. …”
Get full text
Article -
95
Relationship between Neovascular Density in Swept Source-Optical Coherence Tomography Angiography and Signs of Activity in Exudative Age-Related Macular Degeneration
Published 2019-01-01“…This study demonstrated the potential usefulness of SS-OCTA for guidance of treatment in age-related macular degeneration.…”
Get full text
Article -
96
Opportunities, challenges, and difficulties in NMR-based metabolomics applied to neovascular age-related macular degeneration (nAMD) patient follow-up
Published 2025-01-01Subjects: “…age-related macular degeneration…”
Get full text
Article -
97
-
98
Mask-UnMask Regions (MUMR) Framework for Classifying AMD Grades Using Inter-Regional Interaction Analysis
Published 2025-01-01Subjects: “…Age-related macular degeneration…”
Get full text
Article -
99
Mesenchymal stem cell‐derived exosomes mitigate amyloid β‐induced retinal toxicity: Insights from rat model and cellular studies
Published 2025-01-01Subjects: “…age‐related macular degeneration…”
Get full text
Article -
100
Efficacy Comparison of Intravitreal Anti-VEGF Therapy for Three Subtypes of Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
Published 2018-01-01“…Intravitreal antivascular endothelial growth factor (anti-VEGF) therapy has been widely used for the treatment of neovascularization (NV) secondary to age-related macular degeneration (AMD). This study aimed to compare the efficacy among different subtypes of neovascular age-related macular degeneration (nAMD). …”
Get full text
Article